Sickle cell trait protects against plasmodium falciparum infection

American Journal of Epidemiology

Volumn 176, Issue SUPPL. 7, 2012, Pages

  Billo, Mounkaila A ^a,b,d   Johnson, Eric S ^d   Doumbia, Seydou O ^b,c   Poudiougou, Belco ^b,c   Sagara, Issaka ^b,c   Diawara, Sory I ^b,c   Diakité, Mahamadou ^b,c   Diallo, Mouctar ^b,c   Doumbo, Ogobara K ^b,c   Tounkara, Anatole ^c   Rice, Janet ^d   James, Mark A ^d   Krogstad, Donald J ^d  

^a Malaria Research and Training Center ^*  (United States)

^b Malaria Research and Training Center   (Mali)

^c UNIVERSITY OF BAMAKO   (Mali)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

asymptomatic infection; cohort and cross sectional based studies and analyses; Plasmodium falciparum; sickle cell trait

Indexed keywords

CHILD HEALTH; COHORT ANALYSIS; DISEASE TRANSMISSION; HEALTH RISK; INFECTIOUS DISEASE; PARASITIC DISEASE; SPATIOTEMPORAL ANALYSIS;

ARTICLE; BLOOD SMEAR; CHILD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE TRANSMISSION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MALI; PRESCHOOL CHILD; REINFECTION; SCHOOL CHILD; SICKLE CELL TRAIT;

MALI;

PLASMODIUM FALCIPARUM;

EID: 84867292389     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws323     Document Type: Article

References (39)

1. Marsh K, English M, Crawley J, et al. The pathogenesis of severe malaria in African children. Ann Trop Med Parasitol. 1996;90(4):395-402.
2. Hay SI, Smith DL, Snow RW. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis. 2008;8(6):369-378.
3. Teklehaimanot A, Bosman A. Opportunities, problems and perspectives for malaria control in sub-Saharan Africa. Parassitologia. 1999;41(1-3):335-338.
4. Beet EA. Sickle cell disease in the Balovale District of Northern Rhjodesia. East Afr Med J. 1946;23(3):75-86.
5. Beet EA. Sickle cell disease in Northern Rhodesia. East Afr Med J. 1947;24(6):212-222.
6. Allison AC. The distribution of sickle cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria. Trans R Soc Trop Med Hyg. 1954; 48(4):312-318.
7. Ringelhann B, Hathorn MK, Jilly P, et al. A new look at the protection of hemoglobin AS and AC genotypes against Plasmodium falciparum infection: a census approach. Am J Hum Genet. 1976;28(3):270-279.
8. Nagel RL, Fleming AF. Genetic epidemiology of the beta s gene. Baillieres Clin Haematol. 1992;5(2):331-365.
9. Allison AC. Protection afforded by sickle cell trait against subtertian malarial infection. Br Med J. 1954;1(4587): 290-294.
10. Allison AC. Polymorphism and natural selection in human populations. Cold Spring Harbor Symp Quant Biol. 1964;29:137-149.
11. Gilles HM, Fletcher KA, Hendrickse RG, et al. Glucose-6-phosphate dehydrogenase deficiency, sickling and malaria in African children in southwestern Nigeria. Lancet. 1967; 1(7842):138-140.
12. Hill AVS, Allsopp CEM, Kwiatkowski D, et al. Common West African HLA antigens associated with protection from malaria. Nature. 1991;352(6336):595- 600.
13. Lell B, May J, Schmidt-Ott RJ, et al. The role of red cell polymorphisms in resistance and susceptibility to malaria. Clin Infect Dis. 1999;28(4):794-799.
14. Aidoo M, Terlouw DJ, Kolczak MS, et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 2002;359(9314):1311- 1312.
15. Marsh K. Malaria-a neglected disease. Parasitology. 1992;104(suppl.):S53- S69.
16. Le Hesran JY, Personne I, Personne P, et al. Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait. Int J Epidemiol. 1999;28(4):793-798.
17. Stirnadel HA, Stoeckle M, Felger I, et al. Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania. Trop Med Int Health. 1999; 4(3):187-193.
18. Fleming AF, Storey J, Molyneaux L, et al. Abnormal haemoglobins in the Sudan Savana of Nigeria. Ann Trop Med Parasitol. 1979;73(2):161-172.
19. Raper AB. Malaria and sickling trait. Br Med J. 1955; 1(4923):1186-1189.
20. Sokhna CS, Rogier C, Dieye A, et al. Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission. Am J Trop Med Hyg. 2000;62(2):266-270.
21. Hall CL, Haynes JD, Chulay JD, et al. Cultured Plasmodium falciparum used as antigen in a malaria indirect fluorescent antibody test. Am J Trop Med Hyg. 1978;27(5):849-852.
22. Payne D. Use and limitations of light microscopy for diagnosing malaria at the primary care level. Bull World Health Organ. 1988;66(5):621-626.
23. Hosmer DWJ, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons, Inc; 1989.
24. Cox DR. Regression models and life-tables. J R Stat Soc. 1972;B34:187-220.
25. Rothman KJ, Greenland S, eds. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven, Publishers; 1998.
26. Miller LH, Roberts T, Shahabuddin M, et al. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol. 1993; 59(1):1-14.
27. Modiano D, Petrarca V, Sirima BS, et al. Different responses to Plasmodium falciparum malaria in west African sympatric ethnic groups. Proc Natl Acad Sci USA. 1996;93(23): 13206-13211.
28. Modiano D, Luoni G, Sirima BS, et al. The lower susceptibility to Plasmodium falciparum malaria of Fulani of Burkina Faso (West Africa) is associated with low frequencies of classic malaria-resistance genes. Trans R Soc Trop Med Hyg. 2001;95(2):149-152.
29. Allen SJ, Bennett S, Riley EM, et al. Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia. Trans R Soc Trop Med Hyg. 1992;86(5):494-498.
30. Colombo B, Felicetti L. Admission of Hb S heterozygotes to a general hospital is relatively reduced in malarial areas. J Med Genet. 1985;22(4):291-292.
31. Willcox M, Bjorkman A, Brohult J, et al. A case-control study in northern Liberia of Plasmodium falciparum malaria in haemoglobin S and beta-thalassemia traits. Ann Trop Med Parasitol. 1983;77(3):239-246.
32. Chippaux JP, Massougbodji A, Castel J, et al. Plasmodium falciparum or P. malariae parasitemia in carriers of sickle cell trait in various Benin biotypes. Rev Epidemiol Sante Publique. 1992;40(4):246-251.
33. Mmbando BP, Kamugisha ML, Lusingu JP, et al. Spatial variation and socio-eoconomic determinants of Plasmodium falciparum infection in northeastern Tanzania. Malar J. 2011;10:145. (doi:10.1186/1475-2875-10-145).
34. Baird JK. Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol. 1998;92(4):367-390.
35. Su XZ, Heatwole VM, Wertheimer SP, et al. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell. 1995;82(1):89-100.
36. Friedman MJ. Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci USA. 1978; 75(4):1994-1997.
37. Roth EF Jr, Friedman M, Ueda Y, et al. Sickling rates of human AS red cells infected in vitro with Plasmodium falciparum malaria. Science. 1978;202(4368): 650-652.
38. Pasvol G, Weatherall DJ. The red cell and the malarial parasite. Br J Haematol. 1980;46(2):165-170.
39. Kwiatkowski D. Genetic susceptibility to malaria getting complex. Curr Opin Genet Dev. 2000;10(3):320-324.